SEBP2016

2016年5月16日 星期一
上海东亚富豪大酒店 - 中国上海徐汇区
SEBP2016
Sino -Euro Bio Par tnering
中欧生物医药合作暨投融资大会
项目路演
国际合作
临床平台
产业投资
SEBP2016
Sino -Euro Bio Par tnering
中欧生物医药合作暨投融资大会
SAVETHEDATE!
Biotech, Pharma & Medtech
Industry Insight
Investment Guide in Europe
European SMEs Showcase
Effective Partnering Platform
Academic - Hospital - Industry
LINK
SEBP OFFICIAL
WEBSITE
16th May,2016
RegalEastAsia,Shanghai
Sino-Euro BioPartnering (SEBP) is an
annual event that proposes a costeffective and tailor-made business
platform for European SMEs to
partner with leading local companies.
Following the increasing demand from
European SMEs for an effective
partnering platform in China, SEBP
was first launched in 2013 by G-Med
Consulting and a network of European
bioclusters
and
governmental
organisations. SEBP benefits from an
exclusive network of Chinese and
European companies in the medical
and pharmaceutical fields as well as
the support of some influential
associations.
SEBP2015
Agenda
Partnership: Research – Clinician – Business –Investment
16 May, 2016, Monday
Agenda (Functional Hall, 2
nd
Floor)
B2B Meetings
(Agenda (Functional
nd
Hall, 2 Floor))
Registration
08h00 - 17h30
Opening （Head of Xuhui District，Head Dept of Economy, Canton Basel-Stadt）
Plenary session
Keynote 1: “Translational medicine in Shanghai Zhongshan Hospital”
President, Zhongshan Hospital
Keynote 2: “Shanghai Fenglin Life Science Park－The perfect platform for
innovation and development
President, Shanghai Fenglin Life and Healthcare Group
Keynote 3: “The Basel Biomedical Experience sharing”
Health Minister, Basel Area
Keynote 4: “Investment in European Life Science－in depth analysis by region”
KPMG（Europe） Director
Coffee break
Showcase I
8 projects
Moderator: GM, BaselArea China Business Platform
One to One
（B2B）
Lunch
13h30 - 15h00
Showcase II
6 projects
Moderator: CEO，Swissnex
Panel Discussion 1：“How to best integrate the research-clinicians-in dustr y”
Moderator
Panelist
GM Shanghai Juke Life Science Park
Deputy Managing Dirctor, Biowin
GM, Roche（China）
GM, J&J Innovation Center (China)
CEO, Medgate
One to One
（B2B）
Coffee break
Showcase
III
6 projects
Moderator: Co-Chair, French Healthcare Alliance
17h00 - 17h40
17h30
Panel Discussion 2：“Cross border partnership and investment opportunities”
Moderator
VP and Global Head, Roche Partnering Asia & Emerging Markets
Panelist
Partner, Law Firm
Partner, Venture Company
General Manager, Local Pharmaceutical Company
Closing
One to One
（B2B）
EUROPEANSMEsINTERESTSATHEART
|Keytopics:
“Translational medicine in Shanghai Zhongshan Hospital”
“ Investment in Europe, in depth analysis by region”
“ How to best integrate the research-clinicians-industry”
“ The Basel biomedical experience sharing”
“ Cross border partnership and investment opportunties”
|Showcase:
AbouttwentycompaniesfromEurope,IsraelandChinawill
presenttheirprojectsandbusinessinterests,whichcover
biotech,IVDandmedtech toover200expertsfromthe
industryandinvestmentcommunity
“I atte nded SEBP 2013 in Shanghai: I had a ve ry pos itive
impress ion. In m y opinion, it is the right place to mee t the
Chinese scie ntific community, to s hare opinions and bus iness
opportunities , which mus t then be consolidated in se veral
separate mee tings. Howeve r, the proactive and inform al
atmos phere is very productive, and is a great facilitator for
the firs t contacts be tween differe nt cultures and bus iness
styles. I consider the participation to SE BP a gre at
opportunity and the right investme nt for companies willing
to explore potential partnerships into China.”
Dr.Domenico Criscuolo
CEOGenovax (Italy)
LINK
SEBP2016
PROGRAMME
“SEBP is a spe cialize d partnering fair selecting spe cific
spotlight topics of inte rest and which provides unique
opportunity to s hare not only China market ins ights but also
European biotech and me dical company’s developme nt and
comme rcial focus. We did attend the confe rence se veral
time , prese nting our new products and technologies to
Chinese potential partne rs s pecially during the roads how.
These presentations were often followed by B2B dis cussions
and did initiate business opportunities. We do appreciate
the conference and wish gre at success in the following
years.”
Dr.Thierry Leclipteux
CEOCoris BioConcept (Belgium)
SEBP2016
Projects
Country
Sector
Switzerland
Medical Device
Switzerland
Medical service
Switzerland
Medical Device
Germany
Medical Device
Singapore
IVD
France
Diagnostics
Summary
Interest
Brand generic orthopeadics anddental implant producers, including artificial M&A or equity investment,
joint, andspinal implants
partnership
One ofthe world leading telemedicine companies provides medical real time
Local partnership
solutionsforpatients
A well eastablished dental implant company with wide range of
Distributor
orthopeadics products
A leading 3Dbiotechnology company – usesbioprinting andbiomaterials
technologies tocommercialize unique biomedical products.In 2014-16.The
company islaunching a stream ofproprietary productsfordental &
Funding andpartner
orthopedic applications with anattainable market of$3.8billion.The
company seeks $55million capital toaccelerate itsgrowth plans.
New generation ofPCR,which couldshorten the reaction time to5-10min. Funding anddistributor
A clinical stage ophthalmological device company building precise, noncontact tonometers based ona novel vibration technology formeasuring
intraocular pressure oreye pressure (IOP)
Funding anddevelpoment
partner
CRO
Provid Specific toolsforhuman biomedical research. Introduces a variety of
new solutionsforacademia, biotech companies and bio-pharmaceutical
Clients and partner
industry thatare looking forinnovative in vivomodels ofhuman biological
mechanisms.
Medical Device
Proprietary medical grade platform for “warm” liver organ transplant. First
CE approved platform foruse ofnormothermic full automated perfusion for
Funding andpartner
liver organ maintenance ofphysiological temperature, pressures, flows,
oxygenation + pHwith bloodat 37°C.
Ireland
Bio-materials
Innovative medical products meeting the unmet needs forthe regeneration
ofbone andcartilage tissue. The company opened in2012.Currently the
company isnow infullscale manufacturing at acertified ISO 13485premisesFunding andpartner
foritsfirst two products– product1forbone regeneration andproduct 2
forcartilage regeneration.
Netherlands
Medical Device
France
UK
Israel
Biotech
Switzerland
Medical Device
Switzerland
Biotech
Unique non-invasive product totreat glaucoma. Selling inEurope and
started the registration process with CFDA in2014.
Red Cisdeveloping a scalable, costeffective productionprocessfor Red C
Universal Red Cells(red cells that are ABO andother antigen free) that
nullifies the introduction ofpotential pathogens andenables extended shelf
Funding andpartner
life without refrigeration. Red CUniversal Red Cells will dramatically improve
meeting the world’s demand forlife saving bloodtransfusionsforthe
breadth ofpatient scenarios and environmental conditions
To improve bonesurgery interms ofspeed, safety, precision and functional
cutsusingpre-operative andnavigation software, advanced robotand
optomechanical technologies combined intoa single device, a compact
automated Computer Assisted and Robot-GuidedLaser Osteotome (CARLO)
Funding
toperform all formsofosteotomies incontact-free mode including
craniomaxillofacial, orthopaedic, skullbase and dentoalveolar surgeries and
dental implantology.
Company focusesonthe discovery anddevelopment ofinnovative small
molecule therapeutics based onlipidkinase (PI3K)andmTOR inhibition for
the treatment ofcancer andinflammatory diseases. While mTOR isa
Partnership
clinically validated drug target, PI3Kinhibitionachieved proofofconcept
statusinclinical PhaseIII. PIQUR hasa secured patent space, hasprotected a
large portion ofrelevant chemical space.
欢迎参加 SEBP2016！
UK
IVD
Strategic / financial investor
[email protected]
A global medical diagnostics businesswith along historyin point-of-care
testing and central laboratory manufacturing. The productshave a hard
earned reputation forease ofuse, reliability andaccuracy. The company
core focusisthe PointofCare market with over 80,000hemoglobin, A1c,
glucose and lactate analyzers inregular useinmore than 100countries
running more than50m testsevery year.
a European pioneer since1996whodevelops, produces andmarkets high
Distributionor acquisition
(sale)
ANIDEALPLATFORMFORCOLLABORATIONS
SIMPLYMEETWITHTHEBESTS
| PreviousChineseparticipants
SINOPHARM • WISON • FOSUN PHARMA • K EHUA • BIOMABS • DIAN
DIAGNOSTICS • CP GUOJI AN • SUNDIA • UPPER BIOTECH • FRONTAGE •
SHENZHEN TIME BOL E • HISUN PHARMA • HD BIOSCIENC ES • SHANGHAI
PHARMA • 3SBIO • WUXI APPTEC • SH ANGPHARMA • MINDRAY •
TIGERMED • NUOKANG BIOPH ARM • T-MAB • FOUNTAI NVEST PARTNERS
• HUA MEDECINE • AB MART • ORBI MED • MEDICILON • WALVAX •
MICROPOT • OMAH A CAPI TAL • SH ANGHAI BIOCHIP • BAYCITY C APITAL •
DAAN GENE • BSK VENTURES • ASC ENTAGE PHARMA • W ONDFO • HUA
PHARMA • GENOR BIOPH ARMA • YANGTZE RIVER PHARMA • PI ONEER
PHARMA • LUYE PH ARMA • KEYBAY • SI MCERE • HENGRUI MEDICINE •
OSMUNDA • BEIXING C APITAL • YUYUE • CH AI TAI TI ANQING PHARMA •
CROWNBIO • DT C APITAL • EDDINGPARM • KINGMED DIAGNOSTICS •
MORNINGSID E • PH ARMALEGACY • QI MING VENTURE • H ENLIUS
BIOTECH • ZERUN BIOTECH • CHINA GRAND • TASLY • WEGO • GREATER
PACIFIC CAPITAL • FARMASINO • FOSUN DIAGNOSITICS …
| PreviousEuropeanparticipants
• Distributors
• Pharma
• Investors
• Medtech / IVD
• CMO/CRO
• Biotech
SEBP2016
REGISTRATION
EarlyBirdfee
(before16th April)
Regularfee
(after16th April)
250Euros*
300Euros*
Onsite
(16th May)
Description
3000RMB***
Conference passgives accessto
keynote speeches, panel discussions,
roadshow and partnering sessions.
The conference alsoprovides
simultaneous translation, lunch &
coffee break, one online
matchmaking account
Conference pass
m Industry,Investor,Services
m Academic,Individual,
Organisation
200Euros*
250Euros*
q Roadshow
250Euros**
300Euros**
NA
Present yourproject tothe audience,
10minutes
(limited toone roadshow /company)
q Poster
120Euros**
120Euros**
NA
Have your poster visible toall the
participants (thefee includesthe
printing cost)
Companypromotion opportunities
*perperson
**percompany(inadditiontotheregistration fee)
***Priceperperson, payableinRMBonly
Toenjoytheearlybird rate,pleaseregisterandarrangethepaymentbeforethe16th ofApril.
Previous Sponsors
Supporting Organisations
We look forward to seeing you
in Shanghai in 2016!
[email protected]
The leading5-starRegalInternationalEast AsiaHotel,
isideallylocatedintheexclusiveHengshan Road.
Withcafés, bars,exquisiteshops andbeautifully
arranged gardens scatteredalongtheboulevard,this
tree-lined promenadestretches tothetwoendsof
famous commercialandleisurecenters - Xu Jia Hui
andHuai Hai Road. Andtheprestigiousdiplomatic
districtiswithinwalkingdistancefromShanghai's
bestdining,shopping,nightlifeandentertainment
venues.
Room
（RMB）
Free
DeluxeRoom
900
Breakfast andInternet
PremierRoom
1100
Breakfast andInternet
ExecutiveRoom
1,600
Breakfast andInternet
Deluxe suiteRoom
3,200
Breakfast andInternet
http://RegalHotel.com
Hotel
OurluxuryShanghaihotelcomprisesatotalof320
guest rooms.Allourroomsare tastefullydesigned in
acontemporarysettingwithhintsofOrientalflair,
offeringguests tranquilityandserenityinarelaxed
environment.